100
working to improve people's quality of life
Advanced Therapy MP
Mesenchymal stem cells with enhanced therapeutic capabilities.
Wound Healing
Medical Devices for the treatment of damaged skin and chronic wounds.
Skin care
Pharmceutical quality active ingredients and cosmetic products for skin care.
Third party manufacturing
Histocell has two manufacturing facilities, both certified by the Spanish Drug Agency. One 2000 m sq for medical devices and dermocosmetic products and a manufacturing plant for advanced therapy medicinal products.
Featured
News.
Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by COVID-19
This is the Phase I clinical trial of the cell therapy drug HC016 developed by Histocell, which is being carried out at the Hospital de Cruces (Bilbao), in Spain.
Read more
See you at
Latest news
- Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by COVID-19
- Histocell join forces with seven companies in the Bio-Health area to launch the IMABI project
- Histocell present at the 30th edition of EWMA 2020 VIRTUAL